Cancer Gene Therapy

译名:癌症基因治疗

CANCER GENE THERAPY

SCIEJCR Q1

5-10

2026

影响因子区间

161天

平台估算

投稿周期

52%

2025

中国作者发文占比

费用说明

收费

期刊简介:Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

【译文】癌症基因治疗是癌症研究人员和临床医生必不可少的基因和细胞治疗资源,为读者提供关于癌症基因和细胞治疗最新发展的最新信息。该期刊发表原创的实验室和临床研究论文、病例报告和综述文章。发表的主题包括RNA干扰方法、耐药性、造血祖细胞基因转移、癌症干细胞、细胞治疗、同源重组、核酶技术、反义技术、肿瘤免疫治疗和肿瘤抑制因子、转化研究、癌症治疗、基因递送系统(病毒和非病毒)、反基因治疗(反义、siRNA和核酶)、细胞凋亡;机制和疗法、疫苗开发、免疫学和免疫治疗、DNA合成和修复。癌症基因治疗发表基因转移/基因治疗和细胞治疗领域实验室研究、临床前研究和临床试验的结果。发表的论文类型包括原创研究论文;病例报告;简报;关于药物耐药性/敏感性、基因治疗、细胞治疗、肿瘤抑制因子和抗癌基因治疗、细胞因子/肿瘤免疫治疗等主要领域的综述文章;行业观点;以及编辑信。

出版社
Springer Nature
语言
English
学科
医学
ISSN
0929-1903
eISSN
1476-5500
出版频率
月刊
创刊年份
1999
投稿网址
https://mts-cgt.nature.com/
最近更新
2026-04-02 18:16:40
Cancer Gene Therapy

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间5-10
暂无